Troikaa Pharmaceuticals
Ahmedabad, India· Est.
Indian‑based pharma leader delivering patented NDDS products for pain, dermatology and critical care worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian‑based pharma leader delivering patented NDDS products for pain, dermatology and critical care worldwide.
Pain ManagementDermatologyCritical CareAnesthesiologyCardiologyGynaecologyNutraceuticals
Technology Platform
Proprietary Novel Drug Delivery Systems (NDDS) that improve bioavailability and patient compliance across injectable, topical and oral dosage forms.
Opportunities
Expansion into EU and US markets via FDA and EU‑GMP approvals, and leveraging NDDS expertise to capture growing demand for pain and dermatology therapies.
Risk Factors
Regulatory approval timelines, competition from larger generic manufacturers, and reliance on a patented portfolio that may face challenges from biosimilar entrants.
Competitive Landscape
Competes with Indian generics leaders such as Sun Pharma, Cipla and Dr. Reddy’s, differentiating through proprietary NDDS technologies and a strong global patent portfolio.